Table 2

Clinical characteristics of patients with a rapid decline in renal function (>5 mL/min/1.73 m2/year)

Rapid decline in eGFR
No decline in eGFR
p Value
Age (years)72.1±8.471.6±9.30.486
Body mass index (kg/m2)27.5±4.528.2±4.60.039
Women (%)41.941.70.960
Permanent AF (%)42.343.60.720
Ankle-Brachial Index ≤0.90 (%)26.519.30.015
Arterial hypertension (%)88.785.10.152
Diabetes (%)
Heart failure (%)19.618.60.736
History of stroke/TIA (%)
History of MI/CHD (%)19.617.80.523
Antiplatelet (%)
ACE inhibitors/ARBs (%)69.474.40.068
β blockers (%)51.547.20.222
Calcium channel antagonists (%)27.826.90.768
Statins (%)43.644.70.761
  • ACE, angiotensin converting enzyme; AF, atrial fibrillation; ARBs, angiotensin receptor blockers; CHD, coronary heart disease; eGFR, estimated glomerular filtration rate; MI, myocardial infarction; TIA, transient ischaemic attack.